Source link : https://www.newshealth.biz/health-news/statin-antibiotic-combo-shows-no-benefit-for-decompensated-cirrhosis/
(MedPage Today) — Adding simvastatin and rifaximin to standard therapy for decompensated cirrhosis does not improve clinical outcomes, a double-blind phase III trial showed. For the primary endpoint, no significant difference emerged for the… Source link : https://www.medpagetoday.com/gastroenterology/generalhepatology/114092 Author : Publish date : 2025-02-05 18:13:28 Copyright for syndicated content belongs to the linked Source.
Author : News Health
Publish date : 2025-02-05 18:13:28
Copyright for syndicated content belongs to the linked Source.